Linda Härmark

Drug Safety Research Unit appoints Linda Härmark as its Director

The Drug Safety Research Unit has announced Linda Härmark as its new Director.

She succeeds Professor Saad Shakir who officially steps down from the position after 26 years.

Linda joins the DSRU, which is based in Southampton, from the Netherlands Pharmacovigilance Centre, Lareb, where she has been Deputy Director for the past four years.

A pharmacist by training, Linda has over 20 years of experience in pharmacovigilance and holds post-graduate qualifications including a PhD and MBA.

Linda said: “I’m honoured to be named the new Director of the DSRU and to continue the important work that Professor Shakir has dedicated his career to.

“Now more than ever, we must protect the safety of patients and communicate the safe and effective use of medicines not only in the UK but around the world.

“I am looking forward to working with the team and supporting them in delivering efficient and robust studies to increase the knowledge about adverse drug reactions.”